ATE172249T1 - Monoklonale antikörper gegen katzen-t- lymphotropes lentivirus - Google Patents

Monoklonale antikörper gegen katzen-t- lymphotropes lentivirus

Info

Publication number
ATE172249T1
ATE172249T1 AT90900599T AT90900599T ATE172249T1 AT E172249 T1 ATE172249 T1 AT E172249T1 AT 90900599 T AT90900599 T AT 90900599T AT 90900599 T AT90900599 T AT 90900599T AT E172249 T1 ATE172249 T1 AT E172249T1
Authority
AT
Austria
Prior art keywords
monoclonal antibodies
antibodies against
against cat
lymphotropic lentivirus
lymphotropic
Prior art date
Application number
AT90900599T
Other languages
English (en)
Inventor
Thomas P O'connor
Quentin J Tonelli
Original Assignee
Idexx Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26960008&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE172249(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Idexx Lab Inc filed Critical Idexx Lab Inc
Application granted granted Critical
Publication of ATE172249T1 publication Critical patent/ATE172249T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1143—Gag-pol proteins, e.g. p17or p24
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT90900599T 1988-12-05 1989-12-05 Monoklonale antikörper gegen katzen-t- lymphotropes lentivirus ATE172249T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27998988A 1988-12-05 1988-12-05
US07/293,906 US5219725A (en) 1988-12-05 1989-01-05 Monoclonal antibodies to feline-t-lymphotropic lentivirus

Publications (1)

Publication Number Publication Date
ATE172249T1 true ATE172249T1 (de) 1998-10-15

Family

ID=26960008

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90900599T ATE172249T1 (de) 1988-12-05 1989-12-05 Monoklonale antikörper gegen katzen-t- lymphotropes lentivirus

Country Status (8)

Country Link
US (5) US5219725A (de)
EP (1) EP0446273B1 (de)
JP (1) JP2893480B2 (de)
AT (1) ATE172249T1 (de)
CA (1) CA2004478C (de)
DE (1) DE68928834T2 (de)
ES (1) ES2124215T3 (de)
WO (1) WO1990006510A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219725A (en) * 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
JP3058685B2 (ja) * 1989-05-08 2000-07-04 アイデックス ラボラトリーズ インコーポレーテッド ネコｔ細胞リンパトロピック レンチウィルスのポリペプチド
FR2669338A1 (fr) * 1990-11-21 1992-05-22 Centre Nat Rech Scient Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
ATE160358T1 (de) * 1991-06-14 1997-12-15 St Vincents Inst Med Res Detektion des immunschwäche-virus aus felis
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US6300118B1 (en) 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
US6458528B1 (en) * 1998-05-15 2002-10-01 Idexx Laboratories, Inc. Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers
US6764676B1 (en) 1998-08-24 2004-07-20 Pfizer Inc. Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus
AU3498200A (en) 1999-02-19 2000-09-04 Michigan State University An antigen test to detect equine protozoal myeloencephalitis in horse serum and cerebrospinal fluid
EP1074625A3 (de) * 1999-06-14 2002-01-02 Pfizer Products Inc. DNS impfstoff gegen das immunschwächevirus der Katze
AU2002244103A1 (en) * 2001-02-22 2002-09-12 University Of Florida Materials and methods for detecting, preventing, and treating hiv and fiv retroviral infection
US7345152B2 (en) * 2002-09-12 2008-03-18 Wyeth Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency-encoded glycoprotein
ATE435425T1 (de) * 2003-09-11 2009-07-15 Idexx Lab Inc Verfahren zum nachweis des felinen immunschwächevirus
AU2005267607B8 (en) * 2003-09-11 2009-07-16 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2005062053A2 (en) * 2003-12-18 2005-07-07 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2005080939A2 (en) * 2004-02-19 2005-09-01 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
JP4866848B2 (ja) * 2004-06-30 2012-02-01 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルス（ｆｉｖ）のｅｎｖタンパク質のｖ３領域に由来するペプチドの使用を含むｆｉｖを検出するための方法および装置
AU2005267605B2 (en) * 2004-06-30 2009-03-26 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US7291338B2 (en) * 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US8287810B2 (en) * 2007-06-20 2012-10-16 Board Of Trustees Of Michigan State University Electrically-active ferromagnetic particle conductimetric biosensor test kit
WO2011123781A1 (en) 2010-04-02 2011-10-06 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus
US8859297B2 (en) 2011-05-23 2014-10-14 Board Of Trustees Of Michigan State University Detection of conductive polymer-labeled analytes
US10739337B2 (en) 2011-08-30 2020-08-11 Board Of Trustees Of Michigan State University Extraction and detection of pathogens using carbohydrate-functionalized biosensors
CN120965872B (zh) * 2025-10-21 2025-12-26 北京溯本源和生物科技有限公司 一种用于检测猫免疫缺陷病毒p24蛋白的单克隆抗体对及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1777014A (en) * 1929-08-31 1930-09-30 Packard Testers Inc Egg tester
US4514505A (en) * 1982-05-21 1985-04-30 The Trustees Of Columbia University In The City Of New York Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
US4748110A (en) * 1985-09-25 1988-05-31 Abbott Laboratories Immunoassay for HTLV-III antigens
AU6713287A (en) 1986-01-06 1987-07-09 F. Hoffmann-La Roche & Co. Expression of htlv-iii gag-gene
NZ220200A (en) 1986-05-19 1990-08-28 Viral Technologies Inc Hiv related peptides, antibodies to the peptides and vaccines therefrom
US5118602A (en) * 1987-08-26 1992-06-02 The Regents Of The University Of California Feline T-lymphotropic lentivirus assay
CA1341439C (en) * 1987-08-26 2003-09-23 Niels C. Pedersen Feline t-lymphotropic lentivirus
US5177014A (en) * 1988-12-05 1993-01-05 Idexx Laboratories, Inc. Monoclonal antibodies to feline-T-lymphotropic lentivirus
US5219725A (en) * 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
US6458528B1 (en) * 1998-05-15 2002-10-01 Idexx Laboratories, Inc. Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers

Also Published As

Publication number Publication date
WO1990006510A1 (en) 1990-06-14
CA2004478A1 (en) 1990-06-05
JPH04502856A (ja) 1992-05-28
JP2893480B2 (ja) 1999-05-24
DE68928834T2 (de) 1999-04-29
EP0446273A1 (de) 1991-09-18
ES2124215T3 (es) 1999-02-01
DE68928834D1 (de) 1998-11-19
US20020095027A1 (en) 2002-07-18
US5219725A (en) 1993-06-15
EP0446273A4 (en) 1992-07-08
US6383765B1 (en) 2002-05-07
EP0446273B1 (de) 1998-10-14
CA2004478C (en) 2000-02-15
US20050208481A1 (en) 2005-09-22
US5656732A (en) 1997-08-12

Similar Documents

Publication Publication Date Title
ATE172249T1 (de) Monoklonale antikörper gegen katzen-t- lymphotropes lentivirus
DE3750339D1 (de) HTLV-III umhüllende Peptiden.
ATE87655T1 (de) Markierer der t-zelle aktivierung.
ATE249476T1 (de) Cyclin d1 und seine cdna
DK0871702T3 (da) Cytokin betegnet Lerk-7
DE69029015D1 (de) Antikörper gegen menschlichen Interleukin-6-Rezeptor
NO963168L (no) Immunstimulatoriske monoklonale antistoffer
ES2076142T3 (es) Peptidos para el diagnostico de anticuerpos para htlv-iii, su preparacion y uso.
EP1475442A3 (de) Lymphotropische Polypeptide von dem Lentivirus von den T-zellen der Katze
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
FR2669338B1 (de)
ES2050114T3 (es) Anticuerpos monoclonales humanos para el virus asociado a la linfoadenopatia.
DK157186A (da) Ekspression af immunologisk aktive virale proteiner
DK0457804T3 (da) M-CSF-monoklonale antistoffer, som genkender en neutraliserende, konformational epitop
DE68921360D1 (de) Monoklonale Antikörper von Mäusen gegen das gp41 Protein von menschlichem Immunmangelsyndrom-Virus.
EP0277970A4 (de) Monoklonale antikörper gegen geflügelkrebszellen (ovb3).
DE3854999D1 (de) An karzinoma assoziierte antigene und antikörper, die diese antigene erkennen
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
NO890116D0 (no) Monoklonale antistoffer.
NO984233L (no) Cytokin kalt lerk-8
DE68919521D1 (de) Immuntest zum Nachweis von alpha-Haloacetamiden.
EA199900934A1 (ru) Применение микрочастиц, содержащих адсорбированные на них белок и антитела, для получения фармацевтической композиции для интраназального введения

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee